Cadila Launches First Cheaper Copy of Worlds Top-Selling Drug – NDTVProfit.com
0
Drug maker Cadila Healthcare Ltd said on Tuesday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world’s top-selling drug, at a fifth of its US price.
The drug’s branded version is sold under the name Humira by US firm AbbVie Inc, and costs $1,000 for a vial in the United States. Humira had sales of $3.26 billion in the quarter ended September, accounting for 65 per cent of AbbVie’s total revenue.
A price of $200 a vial would still keep the drug out of reach for most people in India, where more than 70 per cent of the population lives on less than $2 a day and health insurance is scarce.
Read more – NDTVProfit.com